In last trading session, Vigil Neuroscience Inc (NASDAQ:VIGL) saw 0.76 million shares changing hands with its beta currently measuring 1.86. Company’s recent per share price level of $3.03 trading at $0.14 or 4.84% at ring of the bell on the day assigns it a market valuation of $123.86M. That closing price of VIGL’s stock is at a discount of -100.0% from its 52-week high price of $6.06 and is indicating a premium of 50.83% from its 52-week low price of $1.49.
For Vigil Neuroscience Inc (VIGL), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.47 in the current quarter.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
Upright in the green during last session for gaining 4.84%, in the last five days VIGL remained trading in the green while hitting it’s week-highest on Friday, 02/21/25 when the stock touched $3.03 price level, adding 4.11% to its value on the day. Vigil Neuroscience Inc’s shares saw a change of 78.24% in year-to-date performance and have moved 11.81% in past 5-day. Vigil Neuroscience Inc (NASDAQ:VIGL) showed a performance of 49.26% in past 30-days.
Wall Street analysts have assigned a consensus price target of 11 to the stock, which implies a rise of 72.45% to its current value. Analysts have been projecting 11 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -263.04% in reaching the projected high whereas dropping to the targeted low would mean a loss of -263.04% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 4.38% while estimates for its earnings growth in next 5 years are of 8.09%.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC is the top institutional holder at VIGL for having 5.84 million shares of worth $23.35 million. And as of 2024-06-30, it was holding 14.6419 of the company’s outstanding shares.
The second largest institutional holder is NORTHPOND VENTURES, LLC, which was holding about 4.21 million shares on 2024-06-30. The number of shares represents firm’s hold over 10.5722 of outstanding shares, having a total worth of $16.86 million.
On the other hand, Vanguard Total Stock Market Index Fund and abrdn Life Sciences Investors are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 710.14 shares of worth $2.15 million or 1.74% of the total outstanding shares. The later fund manager was in possession of 235.01 shares on Sep 30, 2024 , making its stake of worth around $0.71 million in the company or a holder of 0.57% of company’s stock.
